Published: 22 August, 2019 | Volume 4 - Issue 2 | Pages: 103-109
Figure 2:
Kaplan-Meier survival curves based on combined risk stratification for NTproBNP, cTnI, and IL-6 using dichotimized median cutoff points. Patients with elevated levels of all three biomarkers had significantly higher risk of adverse events compared to those with any one of the biomarkers elevated and those with biomarker concentrations below the median cutoff.
Read Full Article HTML DOI: 10.29328/journal.jccm.1001049 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."